Inventor · disambiguated record
Michael Olin
Also filed as: OLIN MICHAEL · OLIN MICHAEL R · OLIN MICHAEL RAYMOND
11 granted patents·2 pending applications·23 citations·filing 2005–2023
86Inventor score
Top patents by PatentIndex Score
13 records- 0193US11666645B2CD200 inhibitors and methods of use thereofUNIV MINNESOTA·Filed 2022·Granted Jun 6, 2023·2 cites·19 claims
- 0291US11826408B2CD200 inhibitors and methods of use thereofUNIV MINNESOTA·Filed 2020·Granted Nov 28, 2023·2 cites·22 claims
- 0390US10888609B2CD200 inhibitors and methods of use thereofUNIV MINNESOTA·Filed 2016·Granted Jan 12, 2021·4 cites·8 claims
- 0488US9737598B2CD200 inhibitors and methods of use thereofUNIV MINNESOTA·Filed 2015·Granted Aug 22, 2017·5 cites·8 claims
- 0583US10206986B2Annexin II variant compositions and methodsUNIV MINNESOTA·Filed 2014·Granted Feb 19, 2019·7 cites·19 claims
- 0680US10576145B2CD200 inhibitors and methods of use thereofUNIV MINNESOTA·Filed 2017·Granted Mar 3, 2020·1 cites·6 claims
- 0780US2024050543A1Cd200 inhibitors and methods of use thereofUNIV MINNESOTA·Filed 2023·Application pending·0 cites
- 0875US9555074B2Annexin II compositionsOHLFEST JOHN R·Filed 2011·Granted Jan 31, 2017·1 cites·7 claims
- 0971US9364505B2Therapeutic composition for treatment of glioblastomaOLIN MICHAEL RAYMOND·Filed 2011·Granted Jun 14, 2016·1 cites·10 claims
- 1062US10117928B2Annexin II compositionsUNIV MINNESOTA·Filed 2016·Granted Nov 6, 2018·0 cites·7 claims
- 1160US9662377B2Therapeutic composition for treatment of glioblastomaUNIV MINNESOTA·Filed 2016·Granted May 30, 2017·0 cites·15 claims
- 1257US12414983B2CD200AR ligands for cancer immunotherapyUNIV MINNESOTA·Filed 2020·Granted Sep 16, 2025·0 cites·16 claims
- 1343US2007082377A1Cytotoxicity assaysOLIN MICHAEL R·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →